The value of mergers and acquisitions in the global technology sector rose for the first time in over a year in the second quarter of 2023, while M&A deal counts dropped somewhat. . . . → Read More: Infographic – Q2 Tech Merger Values Up, Deals Down
|
|||||
       |
A new company spun-off from a university lab consortium is advancing gene therapies delivered through the lungs to treat rare inherited respiratory diseases. . . . → Read More: University Start-Up Developing Inhaled Gene Therapies 
A new company developing treatments for neurological and psychiatric diseases from aberrant immune system activity is raising $58 million in seed funds. . . . → Read More: Autoimmune Neuro Disease Start-Up Raises $58M 
A company formed by M.D. Anderson Cancer Center and Panacea Venture plans to develop synthetic antibodies as treatments addressing new cancer targets. . . . → Read More: Venture Firm, Cancer Center Start Antibody Biotech Company 
The Department of Health and Human Services is allocating $100 million for venture investments in new technologies to prepare for future threats from Covid-19. . . . → Read More: HHS Directs $100M for Covid-19 Venture Investments 
Since the start of 2021, most news has been gloomy about venture investments, but a report last week suggests corporate venture capital funding worldwide is picking up. . . . → Read More: Infographic – Some Good Corporate Venture Fund News  Comments are closed  Finance  economics, entrepreneurs, equity, investment, statistics, venture capital 
Regeneron Pharmaceuticals, a maker of synthetic biologic treatments, is acquiring Decibel Therapeutics, developer of gene therapies to treat hearing loss and balance disorders. . . . → Read More: Regeneron Acquires Hearing Loss Biotech in $213M Deal Comments are closed Finance, New products biomedical, biotechnology, clinical trials, genomics, investment, life sciences, merger, pharmaceuticals, university 
A new company with a process using artificial intelligence and robotics to speed development of sustained release drugs is raising $4 million in seed funds. . . . → Read More: Long-Acting Drug Start-Up Raises $4M in Seed Funds Comments are closed Finance, New products biomedical, chemistry, engineering, entrepreneurs, equity, investment, life sciences, materials science, mathematics, pharmaceuticals, physical sciences, robotics, venture capital 
A company, spun-off from academic labs that designs and produces new chemicals with artificial intelligence and robotics, is raising $42.7 million in its first venture funding round. . . . → Read More: Digital Chemistry Start-Up Gains $43M in Early Funds One comment - (Comments are closed) Finance, New products biotechnology, chemistry, computer science, engineering, entrepreneurs, equity, investment, life sciences, manufacturing, materials science, mathematics, pharmaceuticals, physical sciences, robotics, software, U.K., university 
Global venture funding for digital health start-ups remains mired at low levels, as the number of investment deals in the second quarter of 2023 dropped to its lowest level in eight years. . . . → Read More: Infographic – Digital Health Venture Funds Remain Stuck Comments are closed Finance biomedical, economics, engineering, entrepreneurs, equity, investment, medical device, software, statistics, venture capital |
||||
|
Copyright © 2023 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
RSS - Posts